| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
VIMTA LABS LTD. (BSE: 524394)
524394 Technical Analysis
3
| As on 19th Apr 2024 524394 SHARE Price closed @ 449.15 and we RECOMMEND Sell for LONG-TERM with Stoploss of 466.46 & Sell for SHORT-TERM with Stoploss of 477.49 we also expect STOCK to react on Following IMPORTANT LEVELS. |
524394SHARE Price
| Open | 476.95 | Change | Price | % |
| High | 476.95 | 1 Day | -6.50 | -1.43 |
| Low | 444.90 | 1 Week | -29.65 | -6.19 |
| Close | 449.15 | 1 Month | -4.85 | -1.07 |
| Volume | 1375 | 1 Year | 83.30 | 22.77 |
| 52 Week High 621.40 | 52 Week Low 365.00 | ||||
BSE INDIA Most Active Stocks
| 532822 | 12.92 | -2.12% |
| 532775 | 1.75 | -1.13% |
| 532648 | 23.94 | 0.21% |
| 532407 | 135.97 | 2.61% |
| 517001 | 0.09 | 12.50% |
| 512149 | 1.00 | -4.76% |
| 504351 | 2.21 | -2.64% |
| 511700 | 1.89 | 1.61% |
| 530557 | 0.72 | 0.00% |
| 511389 | 7.25 | -2.42% |
BSE INDIA Top Gainers Stocks
BSE INDIA Top Losers Stocks
| 524394 Daily Charts |
524394 Intraday Charts |
Whats New @ Bazaartrend |
524394 Free Analysis |
|
|
524394 Important Levels Intraday
| RESISTANCE | 510.91 |
| RESISTANCE | 491.10 |
| RESISTANCE | 478.86 |
| RESISTANCE | 466.62 |
| SUPPORT | 431.68 |
| SUPPORT | 419.44 |
| SUPPORT | 407.20 |
| SUPPORT | 387.39 |
524394 Target April 2024
| 4th UP Target | 654.26 |
| 3rd UP Target | 587.02 |
| 2nd UP Target | 545.46 |
| 1st UP Target | 503.9 |
| 1st DOWN Target | 385.3 |
| 2nd DOWN Target | 343.74 |
| 3rd DOWN Target | 302.18 |
| 4th DOWN Target | 234.94 |
524394 Weekly Target
| 4th UP Target | 536.42 |
| 3rd UP Target | 517.94 |
| 2nd UP Target | 506.52 |
| 1st UP Target | 495.10 |
| 1st DOWN Target | 462.50 |
| 2nd DOWN Target | 451.08 |
| 3rd DOWN Target | 439.66 |
| 4th DOWN Target | 421.18 |
524394 Target2024
| 4th UP Target | 1044.53 |
| 3rd UP Target | 839.04 |
| 2nd UP Target | 712.03 |
| 1st UP Target | 585.01 |
| 1st DOWN Target | 222.59 |
| 2nd DOWN Target | 95.57 |
| 3rd DOWN Target | -31.44 |
| 4th DOWN Target | -236.93 |
VIMTA LABS LTD. ( BSE INDIA Symbol : 524394 )
Sector : Other And Other Stocks in Same Sector
Sector : Other And Other Stocks in Same Sector
524394 Business Profile
Vimta Labs Limited provides contract research and testing services in India and internationally. The company offers analytical testing services for food and agriculture, and drugs and pharmaceutical products, as well as tests water samples for various purposes and specifications. Its environmental assessment services comprise site selection and liability studies; environmental impact assessments; environment management plans; carrying capacity based regional studies; environmental audits; solid and hazardous waste management; risk assessments and disaster management plans; environmental baseline monitoring for air, meteorology, water, soil, noise, ecology, socio-economic, demography, etc.; and industrial emission source monitoring services. The company?s environmental assessment services also include offshore sampling and analysis of marine water and sediments, marine ecological studies, marine impact assessment, rehabilitation and resettlement studies, forestry and ecological studies, geo-technical studies, geological and hydro-geological studies, land use/land cover studies based on remote sensing, socio-economic and due diligence studies, epidemiological studies, wasteland management studies, and study on bio-indicators. In addition, it offers clinical research services, such as phase-I/bioequivalence studies, as well as screening and recruitment services; conducts studies on various dosage forms, such as tablets, capsules, extended release preparations, gels, jellies, solutions, transdermal patches, injectables, etc.; and offers regulatory audit history services. Further, the company offers clinical reference lab services; pre-clinical services to pharmaceutical, biotech, and medical device companies in the areas of pharmacology, DMPK/ADME, toxicology, and bioanalytical; and biopharmaceutical services in the areas of genomics and proteomics. Vimta Labs Limited was founded in 1984 and is based in Hyderabad, India. Address:
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service